Form 4 Tracker
LIGAND PHARMACEUTICALS INC
LGND

20 insider filings · Latest: Jun 12, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 12, 2026Jun 15 9:06 PMJason HaasDirector
Sale
6,461$255.58$1.7M4,981(D)

View →

Jun 11, 2026Jun 12 5:27 PMJason AryehDirector
Sale
4,500$250.00$1.1M102,580(D)

View →

Jun 10, 2026Jun 12 5:27 PMJason AryehDirector
Sale
500$250.00$125.0K107,080(D)

View →

Jun 10, 2026Jun 12 5:26 PMJohn L LamattinaDirector
Sale
4,591$250.88$1.2M26,969(D)

View →

Jun 1, 2026Jun 2 6:22 PMAndrew ReardonCLO & Secretary
Sale
5,000$227.06$1.1M41,382(D)

View →

May 13, 2026May 14 9:08 PMJohn W KozarichDirector
Sale
1,575$223.50$352.0K41,786(D)

View →

May 12, 2026May 14 9:08 PMJohn W KozarichDirector
Sale
459$224.00$102.8K41,786(D)

View →

May 1, 2026May 14 9:08 PMJohn W KozarichDirector
Sale
467$231.80$108.3K41,786(D)

View →

May 1, 2026May 4 8:20 PMAndrew ReardonCLO & Secretary
Sale
5,000$231.31$1.2M41,382(D)

View →

Apr 1, 2026Apr 2 7:43 PMJohn W KozarichDirector
Sale
467$202.23$94.4K42,253(D)

View →

Apr 1, 2026Apr 2 6:56 PMAndrew ReardonCLO & Secretary
Sale
5,000$201.24$1.0M41,382(D)

View →

Mar 6, 2026Mar 31 5:53 PMJohn L LamattinaDirector
Sale
2,161$200.76$433.8K30,724(D)

View →

Mar 23, 2026Mar 25 11:13 AMStephen L SabbaDirector
Sale
1,000$207.87$207.9K32,793(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 12, 2026Jun 15 9:06 PMJason HaasDirector
Option Exercise
4,000$51.566,138(D)

View →

Jun 5, 2026Jun 12 5:27 PMJason AryehDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 7:42 PMMartine ZimmermannDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 7:41 PMStephen L SabbaDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 7:41 PMJohn L LamattinaDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 7:40 PMJohn W KozarichDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 7:35 PMJason HaasDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 7:35 PMNancy Ryan GrayDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 1, 2026Jun 2 6:22 PMAndrew ReardonCLO & Secretary
Option Exercise
5,000$52.2739,444(D)

View →

May 27, 2026May 28 7:43 PMOctavio EspinozaChief Financial Officer
Option Exercise
1,736$63.6217,407(D)

View →

May 13, 2026May 14 9:08 PMJohn W KozarichDirector
Option Exercise
1,575$69.510(D)

View →

May 12, 2026May 14 9:08 PMJohn W KozarichDirector
Option Exercise
459$69.511,575(D)

View →

May 1, 2026May 4 8:20 PMAndrew ReardonCLO & Secretary
Option Exercise
5,000$52.2744,444(D)

View →

Apr 1, 2026Apr 2 6:56 PMAndrew ReardonCLO & Secretary
Option Exercise
5,000$52.2749,444(D)

View →

Mar 6, 2026Mar 31 5:53 PMJohn L LamattinaDirector
Option Exercise
2,161$114.150(D)

View →

Mar 2, 2026Mar 27 9:20 PMOctavio EspinozaChief Financial Officer
Grant/Award
23,527$202.5523,527(D)

View →

Mar 2, 2026Mar 27 8:33 PMTodd C DavisDirector, Chief Executive Officer
Grant/Award
50,058$202.5550,058(D)

View →

Mar 2, 2026Mar 27 8:16 PMAndrew ReardonCLO & Secretary
Grant/Award
21,525$202.5521,525(D)

View →